Grenke AG
LSE:0R97
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Grenke AG
LSE:0R97
|
DE |
|
C
|
Crescita Therapeutics Inc
OTC:CRRTF
|
CA |
|
C
|
Credito Emiliano SpA
F:EAO
|
IT |
|
Eli Lilly and Co
NYSE:LLY
|
US |
|
S
|
Societe Anonyme des Bains de Mer et du Cercle des Etrangers a Monaco SA
LSE:0O80
|
MC |
|
Banco Santander SA
LSE:0HLE
|
ES |
|
P
|
Petroleo Brasileiro SA Petrobras
BCBA:APBRA
|
BR |
|
Heidelberger Beteiligungsholding AG
F:IPOK
|
DE |
|
CVR Energy Inc
LSE:0HRR
|
US |
|
S
|
Smart Powerr Corp
XBER:CR9
|
CN |
Wall St Price Targets
0R97 Price Targets Summary
Grenke AG
According to Wall Street analysts, the average 1-year price target for 0R97 is 20.81 EUR with a low forecast of 11.13 EUR and a high forecast of 29.45 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0R97's stock price target?
Price Target
20.81
EUR
According to Wall Street analysts, the average 1-year price target for 0R97 is 20.81 EUR with a low forecast of 11.13 EUR and a high forecast of 29.45 EUR.
What is the Revenue forecast for Grenke AG?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is -1%.
What is the Operating Income forecast for Grenke AG?
Projected CAGR
33%
Over the last 14 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 33%.
What is the Net Income forecast for Grenke AG?
Projected CAGR
24%
Over the last 14 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 24%.
